Academic Journal
EPIDEMIOLOGY, DIAGNOSIS, MANAGEMENT AND PREVENTION OF STROKE: A NARRATIVE REVIEW.
| Τίτλος: | EPIDEMIOLOGY, DIAGNOSIS, MANAGEMENT AND PREVENTION OF STROKE: A NARRATIVE REVIEW. |
|---|---|
| Συγγραφείς: | Azeez IA; Department of Family Medicine, Federal University of Medical Sciences, Ila-Orangun, Nigeria., Oguniyi OA; Department of Medicine, Afe Babalola University, Ado-Ekiti, Nigeria., Osarenkhoe OJ; Department of Medicine, Afe Babalola University, Ado-Ekiti, Nigeria., Adeyemo AK; Department of Mathematics, Nigerian Police Academy Wudil, Kano, Nigeria., Adetona A; Department of Community Medicine, Afe Babalola University, Ado-Ekiti, Nigeria., Lasis AJ; Department of Obstetrics and Gynaecology, Adeoyo Maternity Hospital Ibadan, Nigeria., Aderibigbe YA; Department of Family Medicine, Afe Babalola University, Ado-Ekiti, Nigeria., Alade HK; Department of Radiology Afe Babalola University, Ado-Ekiti, Nigeria., Oyelayo OO; Department of Radiology, University of Ilorin, Nigeria., Abdulraheem AB; Department of Radiology, University of Ilorin, Nigeria., Agbana RD; Department of Community Medicine, Afe Babalola University, Ado-Ekiti, Nigeria. |
| Πηγή: | Annals of Ibadan postgraduate medicine [Ann Ib Postgrad Med] 2025 Dec 31; Vol. 23 (3), pp. 54-66. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Association of Resident Doctors Country of Publication: Nigeria NLM ID: 101491784 Publication Model: Print Cited Medium: Print ISSN: 1597-1627 (Print) Linking ISSN: 15971627 NLM ISO Abbreviation: Ann Ib Postgrad Med Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Ibadan (Nigeria) : Association of Resident Doctors |
| Περίληψη: | Introduction: Stroke is a major public health problem globally, and surviving patients have very high risks of recurrence. Age, sex, ethnicity, transient ischaemic attack(TIA), and hereditary characteristics are non-modifiable risk factors while the major modifiable risk factors for stroke are hypertension, diabetes, lack of physical exercise, alcohol and drug abuse, cholesterol, diet management and cardiac diseases. Objective: The aim of this narrative review was to discuss the current management and prevention of stroke. Methods: In this review, the databases of Medline (PubMed), Scopus, Web of Science and Google Scholar were used for literature search. The MESH terms used included "Diagnosis of Stroke", "Epidemiology of Stroke", "Management of Stroke" and "Prevention of Stroke". The other terms were "Stroke Mimicks" and "Biomarkers of Stroke". Studies that evaluated the current management of stroke in adult patients were included. This article is guided by the Scale for the Assessment of Narrative Review Articles (SANRA). Results: A total of 800 studies were found. After excluding duplicate papers and applying the inclusion and exclusion criteria, 72 studies were included for review. The included studies were published between 2010 and 2025. These studies included 9 Randomised Controlled Ttrials, a cohort study and other studies. Conclusion: Computed tomography (CT) scan of the brain is the most common form of clinical imaging procedure used in the treatment of stroke and Non-contrast CT Scans are usually the first step in imaging process. Diffusion-weighted magnetic resonance imaging (MRI) is the most sensitive imaging technique, it shows ischaemic changes very early and is effective in the evaluation of cerebral changes in ischaemic stroke. Magnetic resonance imaging is more precise in excluding intracranial hemorrhage and MRI with DWI is more accurate in the revealing acute ischemic stroke. Stroke treatment mainly focuses on restoring blood flow to the brain and treating stroke-induced neurological injury. (© Association of Resident Doctors, UCH, Ibadan.) |
| Competing Interests: | The authors declare that there is no conflict of interest. |
| References: | Am J Cardiovasc Drugs. 2018 Oct;18(5):397-403. (PMID: 29845546) Neurocrit Care. 2020 Jun;32(3):647-666. (PMID: 32227294) J Hypertens. 2006 Jul;24(7):1413-7. (PMID: 16794492) J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2214-2227. (PMID: 29705088) Can Assoc Radiol J. 2022 May;73(2):371-383. (PMID: 34569306) Int J Nephrol Renovasc Dis. 2014 Feb 20;7:101-5. (PMID: 24570596) JAMA Netw Open. 2022 Jul 1;5(7):e2223074. (PMID: 35862051) Stroke. 2013 Jul;44(7):2064-89. (PMID: 23652265) Hypertension. 2020 Dec;76(6):1688-1695. (PMID: 33040620) Eur Neurol. 2022;85(5):349-366. (PMID: 35917794) Vessel Plus. 2025;9:. (PMID: 40949500) Lancet Neurol. 2015 Jul;14(7):674-5. (PMID: 26067109) J Clin Med. 2023 Oct 25;12(21):. (PMID: 37959200) Galen Med J. 2023 Aug 21;12:e2993. (PMID: 39430040) Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001153. (PMID: 17636655) Lancet Neurol. 2016 Sep;15(10):1028-34. (PMID: 27450474) Circ Res. 2022 Apr 15;130(8):1230-1251. (PMID: 35420919) Stroke. 2008 Oct;39(10):2902-9. (PMID: 18658039) AJNR Am J Neuroradiol. 2022 Feb;43(2):216-222. (PMID: 34969667) Dis Model Mech. 2021 Dec 1;14(12):. (PMID: 34874055) J Funct Biomater. 2025 Jan 01;16(1):. (PMID: 39852564) J Am Heart Assoc. 2020 Oct 20;9(20):e016987. (PMID: 33043760) Stroke. 2004 Jun;35(6):1364-7. (PMID: 15118169) Neurocrit Care. 2011 Feb;14(1):11-7. (PMID: 21042881) Neurol India. 2011 Mar-Apr;59(2):174-9. (PMID: 21483112) Front Neurol. 2021 Feb 05;12:619721. (PMID: 33633673) PLoS One. 2016 Mar 29;11(3):e0149466. (PMID: 27023901) JAMA Netw Open. 2022 Jul 1;5(7):e2223077. (PMID: 35862050) Neurocrit Care. 2020 Feb;32(1):252-261. (PMID: 31264071) Health Technol Assess. 2017 Mar;21(9):1-386. (PMID: 28279251) JAMA Netw Open. 2022 Jul 1;5(7):e2219416. (PMID: 35862046) Int J Mol Sci. 2020 Oct 15;21(20):. (PMID: 33076218) Vasc Health Risk Manag. 2014 Jun 24;10:375-88. (PMID: 25028556) Neurotherapeutics. 2016 Oct;13(4):719-728. (PMID: 27514673) Lancet. 2012 Jun 23;379(9834):2352-63. (PMID: 22632908) Circ Res. 2017 Feb 3;120(3):472-495. (PMID: 28154098) BMJ Med. 2023 Aug 9;2(1):e000407. (PMID: 37577026) J Transl Med. 2014 Aug 03;12:220. (PMID: 25086655) FP Essent. 2022 Jan;512:11-17. (PMID: 35006660) Stroke. 2009 Aug;40(8):2911-44. (PMID: 19478222) J Neuroimaging. 2017 Jan;27(1):59-64. (PMID: 27300498) Ann Med. 2023;55(2):2251490. (PMID: 37643607) Cerebrovasc Dis. 2006;21 Suppl 2:71-9. (PMID: 16651817) Expert Rev Neurother. 2025 Jun;25(6):675-687. (PMID: 40200903) Eur J Radiol. 2017 Nov;96:133-144. (PMID: 28551302) Rev Physiol Biochem Pharmacol. 2019;176:37-64. (PMID: 30515590) Lancet Reg Health Eur. 2023 May 16;30:100651. (PMID: 37228392) J Neurol. 2020 May;267(5):1353-1357. (PMID: 31970491) J Stroke. 2023 Jan;25(1):2-15. (PMID: 36746378) J Stroke Cerebrovasc Dis. 2024 Aug;33(8):107733. (PMID: 38663647) Curr Opin Neurol. 2019 Feb;32(1):54-59. (PMID: 30239360) Cerebrovasc Dis. 2007;24 Suppl 1:96-106. (PMID: 17971644) Int J Stroke. 2011 Feb;6(1):79-86. (PMID: 21205246) Neuromolecular Med. 2019 Dec;21(4):344-368. (PMID: 30830566) J R Soc Med. 2017 Jan;110(1):9-12. (PMID: 28084167) J Stroke Cerebrovasc Dis. 2014 Mar;23(3):505-10. (PMID: 23721622) Health Technol Assess. 2017 Sep;21(54):1-120. (PMID: 28967376) Stroke Res Treat. 2018 Nov 27;2018:3238165. (PMID: 30598741) Int J Mol Med. 2025 Aug;56(2):. (PMID: 40444496) R I Med J (2013). 2017 Jun 1;100(6):25-29. (PMID: 28564665) Eur J Emerg Med. 2019 Feb;26(1):2-8. (PMID: 29727304) J Intern Med. 2015 Aug;278(2):145-65. (PMID: 26130489) Stroke. 2015 Oct;46(10):2762-7. (PMID: 26265125) Cerebrovasc Dis. 2018;45(5-6):279-287. (PMID: 29936515) |
| Contributed Indexing: | Keywords: Biomarkers; Diagnosis; Epidemiology; Management; Prevention; Stroke mimicks |
| Entry Date(s): | Date Created: 20260325 Date Completed: 20260325 Latest Revision: 20260813 |
| Update Code: | 20260813 |
| PubMed Central ID: | PMC13007323 |
| PMID: | 41878074 |
| Βάση Δεδομένων: | MEDLINE |
| ISSN: | 1597-1627 |
|---|